SCHEMBL6585983

SCHEMBL6585983

O=C(CS(=O)(=O)N1CCC(Cc2ccccc2)CC1)NO

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 2/20 0.62
MMP2 P08253 1/20 0.61
MMP13 P45452 1/20 0.61
HDAC3 O15379 1/20 0.60
HDAC4 P56524 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC7 Q8WUI4 1/20 0.60
HDAC2 Q92769 1/20 0.60
HDAC10 Q969S8 1/20 0.60
HDAC11 Q96DB2 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
HDAC9 Q9UKV0 1/20 0.60
HDAC5 Q9UQL6 1/20 0.60
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
ALDH1A1 P00352 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6795444 0.86 MEN1 (0.61) MMP2MMP13MEN1KMT2ASMN1; SMN2
SCHEMBL6586759 0.83 MAPT (0.60) MMP2MMP13MEN1KMT2ASMN1; SMN2
SCHEMBL14452167 0.83 MEN1 (0.61) MEN1KMT2ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL4654716 0.81 MMP3 (0.85) MMP3MMP2MMP13HDAC3HDAC4
SCHEMBL7034702 0.78 MMP2 (0.55) MMP3MMP2MMP13HDAC3HDAC4
SCHEMBL14452149 0.78 MEN1 (0.58) MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14452185 0.78 MEN1 (0.58) MEN1KMT2ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL29172873 0.77 ALDH1A1 (0.66) MMP2MMP13MEN1KMT2ASMN1; SMN2
SCHEMBL6585216 0.77 MMP3 (1.00) MMP3MMP2MMP13HDAC3HDAC4
SCHEMBL5899024 0.76 MMP2 (1.00) MMP2MMP13MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1036062-B1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS PFIZER LTD (GB) 2004-01-02 EP disclosed
US-6495568-B1 TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES WARNER-LAMBERT COMPANY 2002-12-17 US disclosed
EP-1036062-A1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS Pfizer Limited (GB) 2000-09-20 EP disclosed
WO-1999029667-A1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS PFIZER LIMITED (GB) 1999-06-17 WO disclosed